New pancreatic cancer drug carries a $39,800 monthly list price: What to know - Yahoo Finance

New pancreatic cancer drug carries a $39,800 monthly list price: What to know - Yahoo Finance
Business

Listen to this article

0%

A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA.  Revolution Medicines' oral tablet daraxonrasib, branded as Rasonque, redu… [+4982 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected